Safety of Clarinase, Trazesil Lozenges, Celecoxib, and Oseltamivir During Breastfeeding
Loratadine (in Clarinase) and oseltamivir are safe for breastfeeding mothers, celecoxib should be used with caution but is acceptable for short-term use, pseudoephedrine (in Clarinase) is compatible but may reduce milk supply, and Trazesil herbal lozenges should be avoided due to lack of safety data.
Clarinase (Loratadine/Pseudoephedrine Combination)
Loratadine Component
- Compatible with breastfeeding 1
- Studies demonstrate low levels reach breastfed infants with minimal risk
- Loratadine is considered a first-line antihistamine choice for nursing mothers 1
Pseudoephedrine Component
- Compatible but with important caveats 1
- Low levels transfer to breast milk based on human studies
- Critical warning: May significantly reduce milk supply in some women
- Should be taken at the lowest effective dose and for the shortest duration 1
- Time doses immediately after breastfeeding to minimize infant exposure 1
Clinical recommendation: Use Clarinase only if allergy symptoms are severe enough to warrant the risk of reduced milk production. Consider loratadine alone without the decongestant component as a safer alternative.
Trazesil Herbal Lozenges
Avoid use during breastfeeding 2
- No safety or efficacy data available for herbal cough products during lactation
- Healthcare providers lack evidence-based guidelines for herbal product safety in breastfeeding 2
- The composition and concentration of active ingredients in herbal products are often inconsistent
- Potential for unknown adverse effects on the infant
Alternative: Use codeine-based cough suppressants for short-term use, which are considered compatible with breastfeeding by the American Academy of Pediatrics 1
Celecoxib (Celebrex)
Probably safe for short-term use 3, 4
- Limited data from 12 breastfeeding women show low levels in breast milk 4
- Calculated average infant dose is 10-40 mcg/kg/day, representing less than 1% of the weight-based therapeutic dose for a two-year-old child 4
- Two breastfed infants (17 and 22 months) showed no adverse events 4
Important considerations:
- Avoid in the final 6-8 weeks of pregnancy if still pregnant, but this doesn't apply to breastfeeding 3
- Ibuprofen and naproxen are explicitly listed as safe alternatives in breastfeeding women and may be preferred 3
- Use at the lowest effective dose for the shortest duration 1
- The developmental benefits of breastfeeding should be weighed against the mother's clinical need 4
Clinical recommendation: Celecoxib can be used during breastfeeding when clinically necessary, but consider ibuprofen or naproxen as first-line NSAIDs given their more established safety profile.
Oseltamivir (Tamiflu)
Safe for use during breastfeeding 5
- Excreted in rat milk in animal studies, but human data suggest minimal risk
- The FDA label states it "should be used only if the potential benefit justifies the potential risk" 5, but this conservative language reflects lack of extensive human data rather than evidence of harm
- Given the serious nature of influenza and potential maternal complications, treatment benefits outweigh theoretical risks
- No dose adjustment needed for breastfeeding 5
Practical guidance:
- Begin treatment within 48 hours of symptom onset for maximum efficacy
- Complete the full 5-day course (10 doses) even if symptoms improve 5
- Can be taken with or without food; taking with food reduces nausea risk 5
- Continue breastfeeding while taking oseltamivir
Common Pitfalls to Avoid
- Don't unnecessarily discontinue breastfeeding: Most medications transfer to breast milk in subclinical amounts 6
- Avoid combination products: Many cough/cold products contain multiple ingredients including alcohol; single-ingredient products are preferable 1
- Watch for infant effects: Monitor for irritability/insomnia (from decongestants) or paradoxical CNS stimulation (from antihistamines) 1
- Don't assume herbal = safe: Herbal products lack safety data and should be avoided 2, 7